PMC:7696151 / 30831-31074 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"906","span":{"begin":197,"end":207},"obj":"Species"},{"id":"953","span":{"begin":0,"end":3},"obj":"Chemical"}],"attributes":[{"id":"A906","pred":"tao:has_database_id","subj":"906","obj":"Tax:2697049"},{"id":"A953","pred":"tao:has_database_id","subj":"953","obj":"MESH:D006886"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"HCQ consisted of 200 mg/day for the first three days, followed by 800 mg/day as maintained dosage until the end of the treatment. After 28 days of treatment, there was no significant difference in SARS-CoV-2 negative conversion in either the H"}